Education
About Us
Working with TipRanks
Follow Us
PreveCeutical Medical Inc (PRVCF)
OTHER OTC:PRVCF
RESEARCH TOOLSreports
PRVCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.03
Previous CloseN/A
Volume198.43K
Average Volume (3M)52.35K
Market Cap
$16.51M
Enterprise Value$27.02M
Total Cash (Recent Filing)$59.14K
Total Debt (Recent Filing)C$4.46M
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding565,370,060
10 Day Avg. Volume49,842
30 Day Avg. Volume52,348
Financial Highlights & Ratios
PEG Ratio-0.57
Price to Book (P/B)-3.24
Price to Sales (P/S)0.00
P/FCF Ratio-52.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PreveCeutical Medical News
PremiumCompany Announcements
PreveCeutical Appoints Dr. Deepak Sampath as Corporate Advisor
PremiumCompany Announcements
PreveCeutical Completes Private Placement to Boost R&D Efforts
PremiumCompany Announcements
PreveCeutical’s BioGene Launches New Website to Boost Digital Engagement
PremiumCompany Announcements
PreveCeutical Closes Initial Tranche of Private Placement, Raising $590,001PremiumCompany Announcements
PreveCeutical Upsizes Private Placement to Bolster Financial Position
PremiumCompany Announcements
PreveCeutical Launches Private Placement to Raise $500,000PremiumCompany Announcements
PreveCeutical Extends Private Placement Deadline to April 2025Options Prices
Currently, No data available
---
Ownership Overview
PRVCF FAQ
What was PreveCeutical Medical Inc’s price range in the past 12 months?
PreveCeutical Medical Inc lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is PreveCeutical Medical Inc’s market cap?
PreveCeutical Medical Inc’s market cap is $16.51M.
When is PreveCeutical Medical Inc’s upcoming earnings report date?
PreveCeutical Medical Inc’s upcoming earnings report date is Aug 21, 2025 which is in 73 days.
How were PreveCeutical Medical Inc’s earnings last quarter?
Currently, no data Available
Is PreveCeutical Medical Inc overvalued?
According to Wall Street analysts PreveCeutical Medical Inc’s price is currently Overvalued.
Does PreveCeutical Medical Inc pay dividends?
PreveCeutical Medical Inc does not currently pay dividends.
What is PreveCeutical Medical Inc’s EPS estimate?
PreveCeutical Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PreveCeutical Medical Inc have?
PreveCeutical Medical Inc has 565,370,060 shares outstanding.
What happened to PreveCeutical Medical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PreveCeutical Medical Inc?
Currently, no hedge funds are holding shares in PRVCF
Company Description
PreveCeutical Medical Inc
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
Technical Analysis
Rapid Dose Therapeutics Corp
―
BriaCell Therapeutics
―
Hemostemix
―
Sirona Biochem
―
PharmaTher Holdings Ltd
―